The purine salvage pathway of parasitic protozoa is currently considered as a target for drug development because these organisms cannot synthesize purines de novo. Insight into the structure and mechanism of the involved enzymes can aid in the development of potent inhibitors, leading to new curative drugs. Nucleoside hydrolases are key enzymes in the purine salvage pathway of Trypanosomatidae, and they are especially attractive because they have no equivalent in mammalian cells. We cloned, expressed and puri®ed a nucleoside hydrolase from Trypanosoma vivax. The substrate activity pro®le establishes the enzyme to be a member of the inosine-adenosine-guanosine-preferring nucleoside hydrolases (IAG-NH). We solved the crystal structure of the enzyme at 1.6 A Ê resolution using MAD techniques. The complex of the enzyme with the substrate analogue 3-deaza-adenosine is presented. These are the ®rst structures of an IAG-NH reported in the literature. The T. vivax IAG-NH is a homodimer, with each subunit consisting of ten b-strands, 12 a-helices and three small 3 10 -helices. Six of the eight strands of the central b-sheet form a motif resembling the Rossmann fold. Superposition of the active sites of this IAG-NH and the inosine-uridine-preferring nucleoside hydrolase (IU-NH) of Crithidia fasciculata shows the molecular basis of the different substrate speci®city distinguishing these two classes of nucleoside hydrolases. An``aromatic stacking network'' in the active site of the IAG-NH, absent from the IU-NH, imposes the purine speci®city. Asp10 is the proposed general base in the reaction mechanism, abstracting a proton from a nucleophilic water molecule. Asp40 (replaced by Asn39 in the IU-NH) is positioned appropriately to act as a general acid and to protonate the purine leaving group. The second general acid, needed for full enzymatic activity, is probably part of a¯exible loop located in the vicinity of the active site.
Introduction
Parasitic diseases remain a huge health care problem, especially in developing countries. Trypanosomiasis, or sleeping sickness, is caused by a unicellular protozoon of the genus Trypanosoma. Annually, about 25,000 to 50,000 new cases of sleeping sickness are reported in the sub-Sahara region. [1] [2] [3] Trypanosomiasis is, moreover, one of the most important illnesses of domestic livestock in Africa. Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense are the causative agents of sleeping sickness in human beings, while Trypanosoma vivax, Trypanosoma congolense and Trypanosoma brucei brucei cause the disease in domestic animals and wildlife. It is clear that there is an urgent need for new ef®cient drugs to treat trypanosomiasis, especially since the drugs used at E-mail address of the corresponding author: jsteyaer@vub.ac.be Abbreviations used: PRTase, phosphoribosyltransferase; IU-, inosine-uridinepreferring; IG-, inosine-guanosine-preferring; IAG-, inosine-adenosine-guanosine-preferring; NH, nucleoside hydrolase(s); Ni-NTA, nickel-nitrilotriacetic acid; MAD, multiple wavelength anomalous dispersion; p-nitrophenylriboside or pNPR, para-nitrophenyl b-D-ribofuranoside. present show very high host toxicity. Moreover, the wide-spreading drug resistance makes treatment very dif®cult in large areas of Africa. 4, 5 In this regard, a number of trypanosomal pathways are being investigated as possible targets for drug development. 6, 7 One of these pathways is the purine salvage pathway. 8 All parasitic protozoa (e.g. Plasmodium, Toxoplasma, Leishmania, Trypanosoma) lack the ability to synthesize purine nucleotides de novo. Instead, they use salvage enzymes to obtain purine bases and nucleosides from their hosts and convert them to the corresponding nucleotides. [9] [10] [11] After their uptake by speci®c transporters, 12, 13 the purine nucleosides are ®rst hydrolyzed to ribose and the base by nucleoside hydrolases. The bases are then converted to the concomitant nucleotides by phophoribosyltransferases (PRTases). Interfering with purine salvage by blocking the key enzymes could be an effective way of killing these organisms. The PRTases have already been studied extensively as targets for speci®c inhibitor design. [14] [15] [16] However, due to the many parallel routes that exist in the trypanosomal purine salvage pathways, blocking of this enzyme alone probably will not be enough to kill the parasite. 7 The nucleoside hydrolases form another important and ubiquitous class of purine salvage enzymes. Considering drug development, they have the advantage that, in contrast to the PRTases, no nucleoside hydrolase activity has been reported thus far in mammalian cells. 10 The nucleoside hydrolases catalyze the hydrolysis of the N-glycosidic bond between the anomeric carbon atom of ribose and the purine or pyrimidine base. A nucleoside hydrolase activity has been detected in crude lysates of different species of the Trypanosomatidae. 11, [17] [18] [19] [20] Only four nucleoside hydrolases (two from Crithidia fasciculata.
21,22 one from T. brucei brucei 23 and one from Leishmania major 24 ) have thus far been puri®ed and characterized. These have been divided into three subclasses according to their substrate speci®city. The ®rst class is the base-aspeci®c inosine-uridine-preferring nucleoside hydrolases (IU-NH) found in C. fasciculata 21 and L. major. 24 The other two classes, an inosine-adenosine-guanosine-preferring nucleoside hydrolase (IAG-NH) from T. brucei brucei 23 and an inosine-guanosine-preferring nucleoside hydrolase (IG-NH) from C. fasciculata, 22 show speci®city toward purine nucleosides.
The IU-NHs have been studied in depth. Using kinetic isotope effects, it was shown that the enzyme-catalyzed reaction occurs via an S N 1 mechanism with an oxocarbenium ion transition state. 25, 26 The IU-NHs obtain most of their catalytic power via stabilization of this intrinsically very unstable oxocarbenium ion. Only minor interactions occur with the purine or pyrimidine leaving group. 27 Three IU-NH crystal structures (up to a resolution of 2.3 A Ê ) have been reported. 24, 28, 29 The structural properties of the purine-speci®c nucleoside hydrolases (IAG-NH and IG-NH) have not been characterized. However, the substrate speci®city and the pH-dependence of the kinetic constants indicate that the catalytic mechanisms and the transition state structures are fundamentally different for the IU and IAG isozymes. 23 In comparison with the IU-NHs, the IAG-NHs rely much more on leaving group activation for catalysis. 30 Here, we report the cloning of a nucleoside hydrolase from Trypanosoma vivax, the causative agent of the Souma disease in African cattle. 31 The protein is expressed in Escherichia coli as a Histagged fusion protein that allows easy puri®cation. Determination of the substrate speci®city establishes the enzyme to be an IAG-NH. Kinetic data obtained with a substrate analogue con®rm the importance of leaving group activation in the catalytic mechanism. A 1.6 A Ê resolution X-ray structure of the unliganded protein and a 2.1 A Ê resolution X-ray structure of the protein complexed with the substrate analogue 3-deaza-adenosine are reported. These structures reveal insights into the differences between IU and IAG-NHs and are an indispensable tool for inhibitor design.
Results and Discussion

Cloning and sequence comparison
The cloned cDNA encoding the T. vivax IAG-NH is 1245 nt long and contains a mini-exon or spliced leader sequence from bases 1 to 39. The nucleoside hydrolase ORF codes for a protein of 327 amino acid residues, including the N-terminal methionine residue. For cloning and puri®cation purposes, the start codon was removed and replaced by a sequence coding for 13 amino acid residues, including the six histidine residues from the His-tag. Figure 1 (a) compares the amino acid sequence of the nucleoside hydrolase from T. vivax with the IAG-NH from T. brucei brucei 32 and the IU-NHs from C. fasciculata 27 and L. major. 24 The T. vivax nucleoside hydrolase shares a high sequence identity with the IAG-NH from T. brucei. brucei (66 %). The sequence identity with both IU-NHs is much lower (24 % with the IU-NH from L. major and 26 % with that from C. fasciculata). The IAG-NHs and IU-NHs align best in the regions that have been shown to interact with the ribose part of the substrate in the IU-NH. The residues of the IU-NHs involved in binding of a calcium ion in the active site are conserved in the IAG-NHs. 29 Sequence alignment with the IU-NH is much more dif®cult in those regions that interact with the base of the nucleoside.
Molecular mass and subunit structure
The nucleoside hydrolase subunit structure is quite variable. The IU-NH from C. fasciculata and L. major are homotetramers. 21, 24 The IG-NH from C. fasciculata is a homotrimer. 22 The IAG-NH from T. brucei brucei is a homodimer. We estimated the apparent molecular mass of the active nucleoside hydrolase from T. vivax using gel chromatography on a 10/30 Superdex-200 HR column. The enzyme elutes with a distribution coef®cient (K d in equation (1)) of 0.42 corresponding to a calculated molecular mass of 59,600 Da. Denaturing polyacrylamide gel electrophoresis gave a single band with a subunit molecular mass of approximately 35,000 Da, consistent with the predicted subunit molecular mass of 37,584 Da. The crystal structure (see below) shows the enzyme as a dimer with a large and hydrophobic interface. All data indicate the protein to be a dimer. This means that the enzyme is retarded on the gel-®l-tration column, causing an underestimation of the apparent molecular mass. Alternatively, the enzyme is in a fast equilibrium between the monomeric and the dimeric form in solution.
Substrate specificity
The substrate activity pro®le of the T. vivax nucleoside hydrolase shown in Table 1 is exemplary for an IAG-NH (see also Figure 2 ). The enzyme is a factor of 1000 to 10,000 more speci®c towards the naturally occurring purine nucleosides as compared to the pyrimidine nucleosides, due to both a faster turnover and a higher substrate af®nity (lower K M ) for the former. Table 2 ). This difference is informative for the way the transition state of the enzyme-catalysed reaction is reached. para-Nitrophenylriboside cannot be protonated on the leaving group, but is susceptible to decomposition when the ribosyl group is converted to the oxocarbenium ion. 33 Because the IU-NH obtain most of their catalytic power from stabilisation of the oxocarbenium ion, p-nitrophenylriboside is hydrolysed ef®ciently by this class of enzymes. 27 For the IAG-NHs, leaving group activation is believed to be more important for catalysis, making p-nitrophenylriboside less suitable as a substrate. 30 The compounds 3-deaza-adenosine and 7-deazaadenosine are analogues of adenosine with the nitrogen atom of the purine ring replaced by a carbon atom on position 3 and 7, respectively ( Figure 2 ). Neither of those compounds is hydrolysed at a detectable rate but they bind to the T. vivax IAG-NH with inhibition constants of 0.2 mM and 356 mM, respectively. The observation that 3-deaza-adenosine binds with such high af®-nity indicates that N-3 of the natural purine is not involved in any binding interactions. Nitrogen 7 is most probably involved in one or more binding interactions since the loss of this nitrogen atom Table 1 . Kinetic constants for the nucleoside hydrolase from T. vivax Table 2 . Comparison of kinetic properties of IAG-NHs from T. vivax and T. brucei brucei, IU-NHs from C. fasciculata and L. major, and IG-NH from C. fasciculata results in a decrease of 4.6 kcal/mol in binding energy as compared to 3-deaza-adenosine.
Influence of the His-tag
The kinetic studies on the T. vivax nucleoside hydrolase were carried out with an N-terminally His-tagged enzyme. One could imagine that such a fusion peptide would in¯uence the kinetic characteristics of the enzyme. In order to exclude this possibility, a construct was made with a thrombin cleavage site between the His-tag and the nucleoside hydrolase protein itself. After puri®cation the His-tag was cleaved off and total removal was con®rmed on a Western blot. Table 1 shows that the kinetic parameters for inosine are comparable for the His-tagged and non-His-tagged enzyme, establishing that the N-terminal His-tag does not in¯u-ence the kinetic properties of the IAG-NH.
Description of the overall structure The 1.6 A Ê resolution structure of the unliganded T. vivax IAG-NH has been solved using the MAD phasing method on a samarium derivative, as described in Materials and Methods (see Tables 3  and 4 for data collection and re®nement statistics). Although the density for most of the structure was well de®ned (Figure 3 ), the 12 amino acid residues between methionine 244 and tyrosine 257 are missing from the electron density of both subunits in the asymmetric unit.
The asymmetric unit of the crystal structure contains a homodimer, with each monomer being a single-domain, globular protein ( Figure 4 ). Each subunit consists of ten b-strands, 12 a-helices and three short 3 10 helices ( Figure 5 ). The overall topology diagram of the monomer is shown in Figure 1 (b). Eight of the ten b-strands form a central mixed b-sheet (b1-b7 and b10), with seven parallel strands and one antiparallel strand (b7). The ®rst six strands of this sheet (b1-b6), and the a-helices 1-7, form a motif that resembles the Rossmann fold. 34 The ®rst babab motif of this classical fold is known to be involved in nucleotide binding. Exceptionally, the phosphate-binding consensus sequence GXGXXG, 35 normally located in the loop connecting b1 and a1, is not conserved in the nucleoside hydrolases. In the nucleoside hydrolases, this consensus sequence is replaced by an aspartate-rich region involved in calcium binding, explaining their speci®city for nucleosides as compared to nucleotides.
The dimer interface is formed by the helices a3, a9 and a10 of both subunits, with a3 of one monomer interacting with a9 and a10 of the other monomer ( Figure 6(a) ). The accessible surface area buried in the interface is about 885 A Ê 2 , representing about 7 % of the total accessible surface area of a monomer. The subunit-subunit interface is 63 % non-polar, without intermolecular salt-bridges and with only two intermolecular hydrogen bonds between the side-chains of Asp92 and Ser220 of both monomers. This subunit interface is totally different ( Figure 6 ) from that reported in the IU-NHs. The IU-NHs are tetramers and the subunit-subunit interfaces are formed mainly by bstrands and coils, with the subunits pointing in a different relative orientation than they do in the IAG-NH. 24 A 2.1 A Ê resolution crystal structure of the IAG-NH in complex with 3-deaza-adenosine was also solved. Here, ®ve amino acid residues (Cys248-Arg252) were excluded from both subunits of the model, due to poor electron density in this region. No large conformational differences can be observed between the uncomplexed and the 3-deaza-adenosine-complexed T. vivax nucleoside hydrolase. This is in contrast with the IU-NH from C. fasciculata, where large conformational changes were observed in the loops surrounding the active site upon binding of the transition-state analogue p-aminophenyliminoribitol. 29 This different behaviour probably re¯ects a fundamental difference between the two inhibitors. 3-Deaza-adenosine is a substrate analogue and the enzyme-bound species might not have the properties of the transition state necessary to invoke the catalytically important conformational changes.
The active site
The T. vivax IAG-NH dimer contains two active sites that are structurally indistinguishable. Since no cooperativity was observed in any of the kinetic studies, we conclude that both active sites function independently. The active sites are located at the C-terminal ends of the core eight-stranded b-sheet Table 3 . Data collection, scaling and phase re®nement statistics for high-resolution native data, MAD data and data of the 3-deaza-adenosine complexed structure 
, where I i (hkl) are the intensities of multiple measurements and hI i (hkl)i is the average of the measured intensities for the ith re¯ection.
R cullis AEjjjF PH (hkl)j AE jF P (hkl)jj À jF H (hkl)jj/AEjjF PH (hkl)j AE jF P (hkl)jj, where F PH , F P and F H are the derivative, native and calculated heavy-atom structure factors, respectively. The sum is extended over all centric re¯ections. of both subunits ( Figure 5 ). The active-site cleft is formed by strands b1, b2, b4 and b5, and helices a1, a3, a10 and a11. A bound octa-coordinated calcium ion is situated in the active site, making contacts with the carboxyl groups of Asp15 (both oxygen atoms), Asp10 and Asp 261, and the mainchain carbonyl group of Thr137 (Figure 7 ). In the unliganded structure, the other three coordination positions are occupied by water molecules (in one of the subunits, one water molecule is replaced by a glycerol molecule from the cryo buffer).
3-Deaza-adenosine is bound in the active site with the ribose interacting with the calcium ion and the base pointing toward the exit of the active site ( Figure 7) . The ribose adopts an O 4 H endo envelope conformation. 36, 37 This conformation is rarely observed in solution, and the energetic cost to ®x a furanose ring in this state is about 3.8 kcal/ mol. 38 The conformation adopted by the exocyclic C 4 H C 5 H bond is antiperiplanar (ap) with torsion angles, f OO 70 and f OC 173 . 39, 40 In the complex, the purine adopts a syn conformation toward the ribose (torsion angle,
), 41 whereas in solution, purine nucleosides are in equilibrium between the syn and the anti conformations. Guanosine has a higher tendency to adopt the syn conformation in solution. 42 This conformational preference of the substrate may contribute to the speci®city of the T. vivax nucleoside hydrolase for guanosine as compared to adenosine (Table 1 ).
In the 3-deaza-adenosine complexed structure, two of the Ca 2 -bound water molecules are replaced by the 2 H OH and 3 H OH groups of the ribose (see Figure 2 for atom numbering of nucleosides). The third water molecule, still bound to Ca 2 , is probably the nucleophile in the S N 1 reaction, since it is positioned ideally to attack the anomeric carbon atom of the ribose (3.34 A Ê ). Asp10 is at hydrogen bond distance from this water molecule (2.58 A Ê ) and could act as an activator of this water nucleophile by abstracting a proton. The calcium ion plays an important role in this regard, probably by lowering the pK a of the catalytic water molecule prior to proton transfer to Asp10. 29 The catalytic water is further coordinated by the amide group of Asn186.
Apart from the interaction between the Ca 2 cofactor and the 2 H OH and 3 H OH groups of the ribose, several enzyme residue side-chains are in contact with 3-deaza-adenosine (Figures 7 and 8) . The enzyme forms hydrogen bonds with all three hydroxyl groups of the ribose. The 5
H OH group interacts with Asn173 and Glu184, while Asn186 and Asp261 are hydrogen bonded with the 3 H OH group. Asp14 occurs in multiple conformations in the unliganded structure. Binding of 3-deazaadenosine ®xes its side-chain in an ideal position to hydrogen bond with the 2 H OH group. One nonpolar residue in the active site, Met164, is forming a van der Waals interaction with the C 5 H . It was previously shown for the IAG-NH from T. brucei brucei that interactions with the 5 H OH group mainly contribute to substrate binding, while interactions with the 2 H OH and the 3 H OH groups are important for the stabilisation of the oxocarbenium ion in the transition state. 23 Extrapolating these results to the T. vivax IAG-NH would mean that the interactions between the 5
H OH group and Asn173 and Glu184 are fully developed in the observed ground state, while the interactions of the enzyme with the 2 H OH and 3
H OH groups would be at full strength only in the transition state complex.
Kinetic studies with the substrate analogue p-nitrophenylriboside 30 (see also Table 1 ) established that a large fraction of the catalytic power for the IAG-NHs is obtained through interactions with the purine leaving group. Protonation of a 
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purine lowers its pK a , thus promoting its departure. Protonation of N-7 has been shown to be involved in the acid-catalysed solvolysis of nucleosides and is a key step in the mechanisms of IU-NHs, nucleoside phosphorylases and AMP nucleosidases. 43, 44 Hydrogen bonds between proteic proton donors and acceptors on the purine may also activate the leaving group by lowering the electron density in the aromatic system. Asp40 is located at 3.5 A Ê from the leaving nitrogen atom (N-9) and is located appropriately to protonate, or hydrogen bond with, N-9 of the purine leaving group. Since the crystals have been soaked with 3-deaza-adenosine at neutral pH, Asp40 is probably in the unprotonated state in this structure. Protonation of this carboxylate group at lower pH would likely induce the Asp40 side-chain to approach the purine N-9 (note that the pH optimum of this enzyme is around pH 5; unpublished results). From the inhibition studies with 7-deaza-adenosine, it appears that the enzyme interacts with the purine N-7 as well. Asn12 is located at 3.89 A Ê from N-7, but given some induced ®t a hydrogen bond might be formed.
The 3-deaza-adenine leaving group is involved in extensive aromatic stacking interactions. The purine is``sandwiched'' between the side-chains of Trp83 and Trp260 (Figure 7 ). Upon binding of 3-deaza-adenosine, the region between Glu82 and Leu86 undergoes a slight conformational change, aligning Trp83 perfectly parallel with the purine base. Heterocyclic aromatic ring systems like purines and tryptophan are frequently involved in these face-to-face stacking interactions. This contributes to the purine-speci®city of the IAG-NHs, since non-heterocyclic pyrimidines can only establish edge-to-face stacking interactions. 45 Edge-toface stacking cannot be accommodated in the active-site pocket. The aromatic network around the leaving group is further completed by Phe79, Trp185 and Tyr257 (see Figure 10(b) ).
Comparison between the IAG-NH and the IU-NH
The different quaternary structure between the T. vivax IAG-NH and the IU-NHs is striking. Totally different secondary structure elements are involved in the subunit interactions in the T. vivax dimer as compared to the IU-NH tetramer from C. fasciculata (pdb1mas) (Figure 6 ). The T. vivax and C. fasciculata monomers differ mostly in the loops around the active site and in the regions involved in the subunit interactions.
We also compared the active sites of the liganded IAG-NH and the IU-NH of C. fasciculata in complex with p-aminophenyliminoribitol (pdb 2mas). Figure 9 illustrates the fact that the inhibitors in both structures are bound in the same position in the active sites. The 2 H OH, 3 H OH and 5 H OH groups of both inhibitors virtually superimpose. The leaving groups (3-deaza-adenine and p-aminophenyl) are bound in an orientation perpendicular to each other.
All residues interacting with the ribose (or the iminoribitol in the case of p-aminophenyliminoribitol) are conserved in the amino acid sequence of IU-NHs and IAG-NHs (Figure 1(a) ) and superimpose very well in the structure (Figure 9(a) ). There is only one exception, Asn39, which interacts with the 2 H OH group in the IU-NH is replaced by Asp40 in the IAG-NH. In the IAG-NH structure, however, the Asp40 side-chain is shifted away from the 2 H OH group toward N-9. It thus appears that Asn39 and Asp40 serve different functions in these related enzymes. Whereas Asn39 stabilises the oxocarbenium ion, Asp40 may contribute to the activation of the leaving group. The different substrate speci®city between IU-NHs and IAG-NHs is re¯ected by a much greater divergence in the structure around the base of the nucleoside substrate (Figure 9(b) ). Ile81 in the IU-NH is replaced by Trp83, which constituted one half of the parallel aromatic stacking sandwich around the purine base in the IAG-NH. The other half of the sandwich is Trp260, which replaces His241 as compared to the IU-NH. The nearly parallel aromatic stacking interactions 46 in the IAG-NH active site, absent from the active site of the IU-NH, contribute to the high speci®city for purine bases of the IAG-NHs. His82 of the IU-NH is not conserved in the IAG-NH, neither. His82 has been proposed to be involved in a cation-p interaction with the leaving group. 29 In the T. vivax IAG-NH, the His82 imidazole group is structurally replaced by the amide group of Asn12 (Figure 9(b) ). Mutagenesis studies are in progress to establish the function of Asn12. Figure 10 . Molecular surface of the T. vivax IAG-NH around the active site, calculated without 3-deaza-adenosine, which is shown in the active site. In (a) the molecular surface is colour coded according to its electrostatic potential. Blue refers to positive and red to negative potential. 3-Deaza-adenosine is clearly bound with its ribose in a highly negatively charged pocket. A number of charged residues, not involved in interactions with 3-deaza-adenosine, surround the active site. These might be employed for inhibitor design. In (b) the aromatic residues (Tyr, Phe and Trp) are colored green and the apolar residues are colored yellow. The calcium ion in the bottom of the active site is shown in blue. The outer side of the cleft clearly has a highly aromatic character. Trp83 and Trp260 form aromatic stacking interactions with the purine. The Figure was generated with GRASP. 71 The quest for proton donors
The pH pro®les and pH optima of the IAG-NH (from T. brucei brucei and T. vivax) differ considerably from those of the IU-NHs. It has been reported that the IAG-NH from T. brucei brucei requires three ionizable residues, one acid with a pK a of 6.5 and two with pK a values of 8.8, all needed in a protonated state for maximal enzymatic turnover (k cat ). Leaving group activation by proton donation to N-3 and N-7 of the purine ring is the proposed role for these residues. 23 For the T. vivax nucleoside hydrolase, two groups, with a pK a of 5.5 and 8.5, are found to be required in a protonated state (unpublished results). The pH pro®le of k cat for the C. fasciculata IU-NH follows a quite different, bell-shaped curve, with a single acid (pK a 9.1) needed in a protonated state and a base (pK a 7.1) required in its deprotonated state. 47 Comparing these pH pro®les, we conclude that both classes of hydrolases require at least one protonated acid with a high pK a that is required for the protonation of the leaving group. Apparently, the IAG-NHs engaged additional catalytic acids (with lower pK a ) to activate the leaving group.
Looking at the crystal structure of the IAG-NH in complex with 3-deaza-adenosine, Asp40 is the best candidate for the low pK a proton donor (pK a 5.5 and 6.5 for the T. vivax and T. brucei brucei nucleoside hydrolase, respectively). Asp40 is in an appropriate position to protonate N-9 of the leaving purine (Figures 7 and 8) . Moreover, Asp40 aligns with Asn39 of the IU-NH (Figure 9(b) ), explaining the absence of a second (low pK a ) proton donor in the pH pro®le of the IU-NH.
The identi®cation of the high pK a proton donor that protonates the leaving group is less obvious from the structure of the IAG-NHs. For the IU-NHs, His241 has been proposed for this role, despite its high pK a of 9.1. 27 In the T. vivax IAG-NH, this histidine residue is replaced by Trp260 (Figure 9(b) ). This tryptophane residue does not correspond to the``high pK a``p roton donor because it does not ionise in the physiological pH range. Tyr257 is a possible candidate, but the distance between the ionizable hydroxyl group of Tyr257 and the exocyclic amino group of 3-deazaadenosine is large and amounts to 3.6 A Ê . However, it should be kept in mind that ring nitrogen and keto oxygen atoms of purines and pyrimidines are preferably protonated as compared to exocyclic amino groups. 40 Most pH pro®les have been determined using inosine as the substrate with a keto oxygen atom at ring position 6.
It is possible that the missing proton donor(s), required for chemical turnover, is situated in that part of the structure (between Met244 and Tyr257) that is poorly de®ned in the electron density. Possibly, this loop undergoes a conformational change during the formation of the transition state to bring these groups into position for catalysis. Thē exible loop hosts a number of ionizable groups (His247, Glu249, Arg252, Asp253 and Asp255) that may serve catalytic functions. Considering the high pK a and the¯exibility of its side-chain, Arg252 is the candidate of choice. Flexible loops containing catalytic residues have been described. In tyrosyltRNA synthase, three catalytic lysine residues and a catalytic arginine residue are part of two¯exible loops. An induced-®t mechanism allows access of the substrates to the active site and enables the transition state to be completely surrounded by groups on the protein that would otherwise block entry. 48 Note that the IU-NH also has a similar exible loop that contains an arginine residue (Arg233). Mutagenesis studies will be needed to positively identify the missing proton donor and to characterise the functional role of the¯exible loop.
Implications for drug design
Nucleoside hydrolases are key enzymes in the purine salvage pathway of trypanosomes and they have no homologous counterparts in mammalian organisms. Blocking these enzymes could provide a means for inhibiting (or slowing) the growth of these parasites. For this purpose, highly speci®c and potent inhibitors are needed. The theory of`a bsolute reaction rates'' implies that enzymes enhance the rate of a reaction to the extent that they bind the altered substrate in the transition state (S { ) more tightly than they bind the substrate in the ground state (S). 49 The catalytic rate enhancement for nucleoside hydrolases is estimated at 6 Â 10 12 . 50 This means that the ES { dissociation constant is of the order of 10 À18 M. 51 Considering this attomolar af®nity, stable analogues of the substrate in the transition state may provide very powerful non-covalent inhibitors. 44 Because IU-NHs obtain most of their catalytic power from oxocarbenium ion stabilisation, inhibitor design against these enzymes has focused on mimicry of the oxocarbenium ion. For example, some iminiribitols have been shown to be subnanomolar inhibitors of IU-NHs and IAG-NHs. In comparison with the IU-NHs, the IAG-NHs rely much more on interactions with the purine for turnover of the substrate. Capturing part of this activating energy in pre-existing, stable oxocarbenium analogues may be the strategy of choice for designing new potent inhibitors. The present crystal structures are valuable tools in the process of inhibitor design. However, one should bear in mind that a crystal structure in complex with a substrate analogue like 3-deazaadenosine might differ considerably from the genuine ES { complex in the transition state, due to conformational changes. For example, the¯exible loop (linking Met244 and Tyr257) may shield more genuine transition-state analogues completely from solvent by an induced-®t mechanism. Several other groups surrounding the active site, e.g. Lys81, Glu82, and Arg84 (Figure 10) , not involved in interactions with 3-deaza-adenosine, may interact with the transition state. Protein engineering is the method of choice for evaluating their role in transition-state binding. Despite the shortcomings of our structures for drug design, one improvement to the inhibitor can be thought of. Since the nucleosides bind to the IAG-NHs in a syn conformation, the introduction of a bulky group (e.g. bromide or uoride) at the C-8 position may increase the af®-nity of any analogue by favouring this conformation in solution. 40 Bromide or¯uoride at this position may interact with Asn12 via a hydrogen bond. The high cooperativity between the interactions in the ES { complex implies that a new feature in an inhibitor that leads to an extra interaction could contribute to a much greater extent to binding af®nity than would be expected for the same isolated interaction. 49 
Conclusions
T. vivax is a causative agent of trypanosomiasis in African cattle. The crystal structures of a T. vivax IAG-NH reported here provide the ®rst structural description of a purine-speci®c nucleoside hydrolase. The structure in complex with the substrate analogue 3-deaza-adenosine sheds light on the mechanism of the enzyme-catalysed reaction. All hydroxyl groups of the ribose are involved in interactions with (mainly acidic) residues of the enzyme and with a calcium ion in the bottom of the catalytic pocket. The speci®city toward purine bases is provided by multiple aromatic stacking interactions between the purine and enzyme residues. While Asp10 is the general base in the reaction mechanism, Asp40 is proposed as a general acid. Comparison of this structure with an IU-NH shows the molecular basis of the different substrate speci®city between both enzyme classes. Mutagenesis studies will be required to identify a proposed second general acid in the enzyme, and to map the individual interactions in the enzyme/substrate or enzyme/transition state complex.
Expression and purification
Overnight cultures of E. coli WK6 cells, 55 containing the iagnh ORF in pQE-30 were used to inoculate 15 baf¯ed¯asks of 300 ml of Terri®c Broth 56 containing 50 mg/l ampicillin. These were incubated at 37 C with shaking until the cells reached an A 600 between 0.6 and 1. The medium was then cooled to 28 C and IPTG was added to a ®nal concentration of 0.5 mM to initiate the expression of the recombinant protein. The next morning, the cells were harvested by centrifugation. The cell pellets were resuspended in 50 mM phosphate buffer (pH 7.0), 1 M NaCl, 1 mM CaCl 2 containing the protease inhibitors leupeptine (1 mg/ml) and 4-(2-aminoethyl)-benzenesulfonyl¯uoride hydrochloride (AEBSF; 0.1 mg/ ml). The cells were lysed via three consecutive passages through a French pressure cell (French 1 Pressure Cell Press, SLM-Aminco 1 Spectronic instruments) and the disrupted cell suspension was centrifuged for 30 minutes at 10,000 rpm in a Beckman JA-20 rotor. The presence of six histidine residues at the N terminus of the recombinant protein allowed an easy puri®cation using Ni-NTA af®nity chromatography (QIAexpress NI-NTA Protein Puri®cation System, Qiagen). The intracellular fraction was applied to a Pharmacia 10/2 HR column packed with Ni-NTA, equilibrated with 50 mM phosphate buffer (pH 7.0), 1 M NaCl using a Pharmacia FPLC system. After extensive washing of the column, the His-tagged nucleoside hydrolase was eluted with 50 mM acetate buffer, pH 5.0 containing 1 M NaCl. The nucleoside hydrolase-containing fractions were neutralized and concentrated using a Vivaspin concentrator (Vivascience). This fraction was then loaded onto a HiLoad 26/60 Superdex-200 column (Pharmacia Biotech Inc.) equilibrated with 20 mM Tris-HCl (pH 8.0), 150 mM NaCl and eluted at 1 ml/minute using the same buffer. The purity of the enzyme after this step was estimated by SDS-PAGE.
The expression and the ®rst step of the puri®cation of the nucleoside hydrolase with removable his-tag were the same as stated above. After the Ni-NTA puri®cation step, the His-tag was cut off by thrombin. The biotinylated thrombin was captured afterwards by passage through a streptavidin column as described in the Thrombin Cleavage Capture Kit (Novagen). The residual, uncleaved, enzyme was removed by a second passage through a Ni-NTA column. Removal of the Histag was con®rmed via Western blotting using mouse anti-his-tag antibodies (Dianova) in combination with an anti-mouse IgG-alkaline phosphatase conjugate (Sigma) for detection.
Molecular mass of the IAG-NH
The elution position of active IAG-NH relative to proteins of known molecular mass (Gel Filtration Chromatography Standard, Bio Rad) was determined by 10/30 Superdex-200 HR gel chromatography. Blue dextran 2000 was used to determine the void volume (V 0 ). The column was eluted with 50 mM Hepes (pH 7.2), 0.3 M KCl at a¯ow-rate of 1 ml/minute. The distribution coef®cients K d :
where V e is elution volume, V 0 is void volume and V t is total volume of the column, of the standard proteins and the IAG-NH were determined graphically from the chromatogram, and plotted against the logarithm of the molecular mass of the standard proteins. This standard curve was used to calculate the apparent molecular mass of the IAG-NH.
Kinetic analysis of substrates and inhibitors
The kinetic properties of the nucleoside hydrolase for the substrates inosine, guanosine and adenosine were determined spectrophotometrically using the difference in absorption between the nucleoside and the purine base. 23 All measurements were carried out at 35 C in 50 mM phosphate buffer (pH 7.2). The Áe values (mM À1 cm À1 ) used were: inosine, À0.92 at 280 nm; adenosine, À1.4 at 276 nm; guanosine, 0.16 at 308 nm. The experimental data were ®tted to the Michaelis-Menten equation using the program Origin (Microcal). For the substrate guanosine, k cat /K M was determined from a single progress curve. The conversion of a subsaturating concentration (5 Â 10 À7 M; S < K M ) of guanosine to guanine was followed on a C18 HPLC column (100 Â 4.6 mm ODS HYPERSIL RP-C18, 5 mm). Substrate and product were eluted with a linear gradient of acetonitrile in water, plus 0.1 % (w/v) trichloroacetic acid and monitored spectrophotometrically at 253 nm. The data were ®tted to the equation:
where: S is substrate concentration, t is time, S 0 is substrate concentration at t 0 and E 0 is total enzyme concentration. The hydrolysis of cytidine and uridine was monitored by the release of reducing sugar at 35 C in 50 mM phosphate buffer (pH 7.2). 23 Hydrolysis of pnitrophenyl b-D-ribofuranoside was followed at 35 C in phosphate buffer (pH 7.5) by release of the p-nitrophenolate anion, which has strong absorbance at 400 nm with an extinction coef®cient of 15 mM À1 cm À1 under the assay conditions. All kinetic parameters were calculated per active site, making them independent of the multimerisation state of the enzyme.
The inhibition constants for 3-deaza-adenosine and 7-deaza-adenosine were determined by measuring the rate of hydrolysis of a ®xed concentration of p-nitrophenyl b-D-ribofuranoside at variable inhibitor concentrations. The results were ®tted to the equation:
where S is substrate concentration, I is inhibitor concentration, E 0 is total enzyme concentration, k cat and K M are steady-state constants for substrate and K I is dissociation constant for the enzyme-inhibitor complex. This analysis requires the assumption that the inhibitor competes with the substrate for the catalytic site. 24 The validity of this assumption is supported by the high structural similarity between both inhibitors and the natural substrates (Figure 2 ) and by the crystal structures reported here.
Crystallization and data collection
All IAG-NH crystals were obtained using the hanging drop vapor diffusion method: 5 ml of protein solution (at 8 mg/ml) was mixed with 5 ml of reservoir solution containing 100 mM Tris (pH 8.5) with 1.6 M ammonium sulfate as precipitant. Crystals with average dimensions of 0.3 mm Â 0.3 mm Â 0.05 mm grew after one to two weeks. The space group and the cell parameters of the different crystals used are given in Table 3 . The crystal used for the high-resolution native dataset was transferred to a cryo solution, which contained 100 mM Tris (pH 8.5), 1.6 M ammonium sulfate and 35 % (w/v) glycerol. Data were collected at 100 K on beamline BW7B of the EMBL outstation at DESY (Hamburg, Germany) using a MAR345 (Hamburg, Germany) image plate.
A samarium derivative was obtained by soaking a crystal for two days in mother liquor containing 5 mM samarium(III) acetate hydrate (Sm(O 2 C 2 H 3 ) 3 ). The crystal was transferred to the same cryo solution as mentioned above and a three wavelength MAD 57 was collected on a single crystal at 100 K on beamline BW7A (EMBL, Hamburg) using a MAR (Hamburg, Germany) CCD detector. The presence of samarium was con®rmed with a¯uor-escence scan and the wavelengths were set to 0.9497 A Ê (remote, l1), 1.6952 A Ê (peak, l2) and 1.6961 A Ê (in¯exion point, l3).
The complex with the substrate analogue 3-deaza-adenosine was obtained by soaking a crystal for two days in 100 mM Hepes (pH 7.5) containing 40 % (w/v) PEG 6000 and 3 mM 3-deaza-adenosine. This solution was also used as cryo solution for the data collection.
Data was collected at 100 K on beamline BW7A (EMBL, Hamburg).
Data processing
The high-resolution native data and the MAD data were indexed and integrated using DENZO/HKL, 58 and scaled and merged with SCALA and other routines from the CCP4 59 program package. The data for the 3-deazaadenosine complex were processed and scaled with the HKL package. Intensities were converted to structure factors with TRUNCATE. Relevant statistics for the data sets are summarized in Table 3 .
Structure determination
The high-resolution native data and the different MAD data were scaled relative to the l1 data set with SCALEIT (CCP4). Difference and anomalous difference Patterson maps were calculated. Heavy-atom positions were localized using PEAKMAX (CCP4) and con®rmed with SHELX (60) . Two samarium positions were found. These sites were re®ned and used for phasing in MLPHARE (CCP4). Five additional Sm positions were identi®ed in difference Fourier maps. Phases were improved with the density modi®cation procedure as implemented in DM, 61 using the solvent-¯attening and histogram-matching options. Phases were extended from 2.3 to 1.6 A Ê . The density modi®cation procedure was hampered by an overestimate of the ®gures of merit (FOMs) by MLPHARE. Therefore, the FOMs were scaled by 0.7 manually before running DM. Visual inspection of the modi®ed electron density map did not allow straightforward building of the protein model. However, part of the structure could be built automatically with the warpNtrace mode in ARP/WARP. 62 The warp model represented mainly one of the two protein chains of the asymmetric unit. To speed up the process, the second protein chain was located using a molecular replacement step using AMoRe. 63 The NCS operator relating the two protein chains was identi®ed, and a mask was calculated with NCSMASK (CCP4). At this point, the density modi®cation step was repeated, combining the solvent-¯attening and histogram-matching procedures with NCS averaging. ARP/WARP automatic structure building was resumed using the improved electron density map. Structure building was ®nished manually using TURBO. 64 
Structure refinement
The warp model was subjected to the simulated annealing procedure as implemented in CNS, using the native data between 30.0 and 1.6 A Ê . [65] [66] [67] The resulting model was corrected manually in TURBO. After several cycles of positional and temperature-factor re®nement combined with manual corrections, solvent molecules and alternative conformations were included in the model. Structure re®nement was considered complete after positional and thermal parameters had converged, and the difference density was without interpretable features. The ®nal model includes 424 water molecules, eight glycerol molecules and two calcium ions. Residues 245 to 256 are missing from both protein chains in the asymmetric unit. The ®nal model has an R-factor of 18.6 % and an R free of 21.0 %.
The crystal structure of the 3-deaza-adenosine complex is isomorphous to the unliganded form. Therefore, re®nement was started from the native structure (without solvent), taking care to use the same set of re¯ections for cross-validation. After an initial round of simulated annealing using CNS, the position of 3-deaza-adenosine could be clearly identi®ed in the 2F o À F c and F o À F c difference maps. The ®nal model of this structure contains one 3-deaza-adenosine molecule per protein chain and 396 water molecules in the asymmetric unit. Residues 248 to 252 are missing from both protein chains. This model has an R-factor of 19.1 % and an R free of 25.4 %. Re®nement of the 3-deaza-adenosine component required a custom restraints ®le. A copy of this ®le will be submitted to the pdb databank complementing the coordinate ®le. Both models were checked with the program PROCHECK. 68 Re®nement statistics are summarized in Table 4 .
Accession numbers
The nucleotide sequence of the T vivax IAG-NH ORF has been submitted to the Genbank TM /EBI with accession number AF311701. The coordinates have been submitted to the RSCB Protein Data Bank with accession number 1HOZ for the unliganded structure and 1HP0 for the 3-deaza-adenosine complexed structure.
